护士健康研究中循环血浆代谢物与类风湿关节炎风险
三个短链酰基肉碱在独立军事队列中重复验证,可能反映血清阳性RA诊断前5年内的炎症。
要点
- 4-乙酰氨基丁酸、N-乙酰腐胺、C5肉碱和C5:1肉碱与RA风险呈负相关。
- C5肉碱、C5:1肉碱和C3肉碱在独立军事队列中与5年内血清阳性RA负相关。
- 短链酰基肉碱可能反映血清阳性RA诊断前5年内的炎症。
核心结论
- 多种代谢物与女性RA发病率呈负相关。
- 三种短链酰基肉碱在较小数据集中重复验证,可能反映血清阳性RA诊断前5年内的炎症。
研究设计与样本
- 测量360种已知代谢物的相对丰度,采用条件logistic回归分析,调整年龄、吸烟和BMI,并考虑多重比较。
- 亚组分析探讨血清阳性RA和采血后5年内发生的RA。
- 显著代谢物在女性军事pre-RA病例对照研究(n=290)中验证。
主要发现
- 在NHS中,与RA和血清阳性RA相关的代谢物包括4-乙酰氨基丁酸(OR=0.80/S.d., 95% CI: 0.66, 0.95)、N-乙酰腐胺(OR=0.82, 95% CI: 0.69, 0.96)、C5肉碱(OR=0.84, 95% CI: 0.71, 0.99)和C5:1肉碱(OR=0.81, 95% CI: 0.68, 0.95)。
- 这些代谢物主要参与多胺以及亮氨酸、异亮氨酸和缬氨酸代谢。
- 在独立军事队列中,与诊断后5年内血清阳性RA相关的代谢物得到重复验证:C5肉碱(OR=0.55, 95% CI: 0.33, 0.92)、C5:1肉碱(OR=0.62, 95% CI: 0.39, 0.99)和C3肉碱(OR=0.57, 95% CI: 0.36, 0.91)。
临床怎么用
- 短链酰基肉碱可能作为血清阳性RA诊断前5年内炎症的潜在代谢标志物。
- 代谢物参与的多胺和支链氨基酸代谢通路可能为RA发病机制提供线索。
局限性
- 研究为观察性设计,不能确定因果关系。
- 验证队列样本量较小(n=290)。
- 研究人群主要为女性护士,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: RA develops slowly over years. We tested for metabolic changes prior to RA onset using a large non-targeted metabolomics platform to identify novel pathways and advance understanding of RA development. METHODS: Two hundred and fifty-four incident RA cases with plasma samples drawn pre-RA onset in the Nurses' Health Study (NHS) cohorts were matched 1:2 to 501 controls on age, race, menopause/post-menopausal hormone use and blood collection features. Relative abundances of 360 unique, known metabolites were measured. Conditional logistic regression analyses assessed associations between metabolites and incidence of RA, adjusted for age, smoking and BMI, accounting for multiple comparisons. Subgroup analyses investigated seropositive (sero+) RA and RA within 5 years of sample collection. Significant metabolites were then tested in a female military pre-RA case-control study (n = 290). RESULTS: In the NHS, metabolites associated with RA and sero+RA in multivariable models included 4-acetamidobutanoate (odds ratio (OR) = 0.80/S.d., 95% CI: 0.66, 0.95), N-acetylputrescine (OR = 0.82, 95% CI: 0.69, 0.96), C5 carnitine (OR = 0.84, 95% CI: 0.71, 0.99) and C5:1 carnitine (OR = 0.81, 95% CI: 0.68, 0.95). These were involved primarily in polyamine and leucine, isoleucine and valine metabolism. Several metabolites associated with sero+RA within 5 years of diagnosis were replicated in the independent military cohort: C5 carnitine (OR = 0.55, 95% CI: 0.33, 0.92), C5:1 carnitine (OR = 0.62, 95% CI: 0.39, 0.99) and C3 carnitine (OR = 0.57, 95% CI: 0.36, 0.91). CONCLUSION: Several metabolites were inversely associated with incidence of RA among women. Three short-chain acylcarnitines replicated in a smaller dataset and may reflect inflammation in the 5-year period prior to sero+RA diagnosis.
引用
- Chu SH, Cui J, Sparks JA, et al. Circulating plasma metabolites and risk of rheumatoid arthritis in the Nurses' Health Study. Rheumatology (Oxford). 2020. PMID: 32310291. doi:10.1093/rheumatology/keaa125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。